Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BEAM
#1724
Beam Therapeutics Inc. - Common Stock
29.2
9
USD
-0.04%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-3.90%
Monthly Change
+11.84%
6 month change
+6.94%
Year Change
+73.62%
Previous Close
30.4
8
Open
29.2
1
Low
29.1
6
High
29.4
1
Volume
147
Markets
US Stock Market
Healthcare
Biotechnology
BEAM
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
News
4 Gene-Editing Biotech Stocks Worth Watching for Long-Term Gains
Tracking Cathie Wood's ARK Invest 13F Portfolio - Q2 2026 Update (BATS:ARKK)
Prime Medicine: An Initial Prognosis (NASDAQ:PRME)
BEAM's Q2 Loss Wider Than Expected, Revenues Fall Y/Y, Pipeline in Focus
Beam Therapeutics Inc. (BEAM) Reports Q2 Loss, Lags Revenue Estimates
Beam Therapeutics: A Valuation With Upside Left (NASDAQ:BEAM)
Myriad Genetics (MYGN) Reports Q2 Loss, Misses Revenue Estimates
The Battle For Sickle Cell
NTLA Surges 38% in a Month: Should You Buy, Sell or Hold the Stock?
Gene Editors, Including Powerhouse Beam Therapeutics, Diverge On Legal Battle
Vertex Pharmaceuticals Has One Of The Widest And Most Durable Moats In Biotech (VRTX)
The Disinflation Trade Has A New Address: Genomics